CapitalCell logo — Invierte en las empresas biomédicas validadas por los mejore...

CapitalCell

Invierte en las empresas biomédicas validadas por los mejores especialistas

Founded 2014 Spain Spain 28 employees Debt Financing Total: $1.69M Biotechnology, Fintech +3

General Information

Company Name CapitalCell
Founded Year 2014
Location Spain Spain
Founders / Decision Makers
Team member
Employees 28
Industries Biotechnology, Fintech, Life Sciences +2
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with CapitalCell. To contact CapitalCell, visit capitalcell.es.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CapitalCell compare?

A PDF of CapitalCell and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CapitalCell soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CapitalCell

CapitalCell is a pan-European crowdinvesting platform focused on biotech & Life Sciences companies, established in 2014. Boasting a unique approach that combines traditional venture capital, business angels, accredited investors, and the power of the Crowd, Capital Cell has positioned itself as a global meeting point for companies and researchers shaping the future of medical science. Their platform serves as a health & biotech marketplace where investors, regardless of their scale, can participate in equity-crowdfunding for non-listed companies. Notably, the platform provides investors with the most accurate scientific and financial information about each project, ensuring transparency and thorough due diligence. The company's slogan, "Invierte en las empresas biomédicas validadas por los mejores especialistas," reflects their commitment to validated biomed companies by top specialists. Headquartered in Spain, CapitalCell recently secured a significant €450.00K Debt Financing investment on 23 January 2024, with participation from John Bethell and ENISA. With its focus on Biotechnology, Fintech, and Pharmaceutical industries, this platform has the potential to continue shaping the future of investment in the life sciences sector, providing a unique gateway for both large and small-scale investors to engage in groundbreaking projects.

Business keywords: equity-crowdfunding, biotech, life sciences, global investors, venture capitalists, business angels, accredited investors, medical science, health marketplace, financial data, researchers, companies, Europe, crowdinvesting, scientific data

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Equity Crowdfunding €200.00K -
23 Jan 2024
Debt Financing €450.00K 2
John Bethell, ENISA
23 Jan 2024
Equity Crowdfunding €910.10K 5
Jordi Riulas, Ian Tomlinson +3
28 Apr 2018
Equity Crowdfunding €125.00K 1
Capital Cell
23 Feb 2016

CapitalCell Alternatives & Competitors

View All Alternatives
CapitalCell vs
Dianox
Dianox Denmark

Scientific innovation that empowers researchers ✨

Non Equity Assistance
12 employees
AI, Biotechnology
CapitalCell vs

The simplest and fastest way to find research reagents

Venture round
23 employees
Biotechnology, E-Commerce
CapitalCell vs
BioSeek JSC
BioSeek JSC Bulgaria

We help convert data into wisdom.

Seed
8 employees
Biotechnology, Data Analytics

FAQ About CapitalCell

Invierte en las empresas biomédicas validadas por los mejores especialistas
CapitalCell was founded in 2014.
CapitalCell is headquartered in Spain.
CapitalCell operates in Biotechnology, Fintech, Life Sciences, Medical Devices and Pharmaceutical. Its work centres on equity-crowdfunding, biotech, life sciences and global investors.
CapitalCell has approximately 28 employees.
CapitalCell has completed 4 funding rounds, raising a total of $1.69M. The latest funding stage is Debt Financing.
Top alternatives and competitors to CapitalCell include Dianox, antibodies-online.com, BioSeek JSC, Benchling, MaxBio Scientific. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CapitalCell and Dianox are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CapitalCell, https://bouncewatch.com/company/capitalcell, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes